APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oseltamivir Phosphate Antiviral Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oseltamivir Phosphate Antiviral Drug Industry Growth and Trends Forecast to 2032

20 December 2025110 pages

Choose your research edition.

Industry ResearchOseltamivir Phosphate Antiviral Drug Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Oseltamivir Phosphate Antiviral Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Oseltamivir Phosphate Antiviral Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oseltamivir Phosphate Antiviral Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Oseltamivir Phosphate Antiviral Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Oseltamivir Phosphate Antiviral Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oseltamivir Phosphate Antiviral Drug include Teva Pharmaceuticals, SL Pharmaceutica, Cspc Holdings, Roche Group, Kelun Pharmaceutical, HEC ChangJiang Pharmaceutical, BrightGene Bio-Medical Technology, Zydus Cadila and Strides Pharma Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oseltamivir Phosphate Antiviral Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oseltamivir Phosphate Antiviral Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oseltamivir Phosphate Antiviral Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oseltamivir Phosphate Antiviral Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oseltamivir Phosphate Antiviral Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oseltamivir Phosphate Antiviral Drug Market by Company

Teva Pharmaceuticals

SL Pharmaceutica

Cspc Holdings

Roche Group

Kelun Pharmaceutical

HEC ChangJiang Pharmaceutical

BrightGene Bio-Medical Technology

Zydus Cadila

Strides Pharma Inc.

Novadoz

Natco Pharma

Macleods Pharmaceuticals

LUPINE Limited

Hetero Group

Camber Pharmaceuticals

Amneal Pharmaceuticals

Alvogen

Alembic Pharmaceuticals

Ajanta Pharma

Oseltamivir Phosphate Antiviral Drug Segment by Type

Capsule

Suspension

Oseltamivir Phosphate Antiviral Drug Segment by Application

Child

Aldult

Oseltamivir Phosphate Antiviral Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oseltamivir Phosphate Antiviral Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oseltamivir Phosphate Antiviral Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oseltamivir Phosphate Antiviral Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oseltamivir Phosphate Antiviral Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oseltamivir Phosphate Antiviral Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Suspension Table 3. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 5. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Oseltamivir Phosphate Antiviral Drug Price by Type (2021-2026) & (US$/unit) Table 9. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2027-2032) & (k units) Table 10. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Oseltamivir Phosphate Antiviral Drug Price by Type (2027-2032) & (US$/unit) Table 14. North America Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 15. North America Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 17. Europe Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 21. Latin America Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Oseltamivir Phosphate Antiviral Drug Industry Trends Table 25. Oseltamivir Phosphate Antiviral Drug Industry Drivers Table 26. Oseltamivir Phosphate Antiviral Drug Industry Opportunities and Challenges Table 27. Oseltamivir Phosphate Antiviral Drug Industry Restraints Table 28. Global Oseltamivir Phosphate Antiviral Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Company (2021-2026) Table 30. Global Oseltamivir Phosphate Antiviral Drug Sales by Company (2021-2026) & (k units) Table 31. Global Oseltamivir Phosphate Antiviral Drug Sales Share by Company (2021-2026) Table 32. Global Oseltamivir Phosphate Antiviral Drug Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Oseltamivir Phosphate Antiviral Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oseltamivir Phosphate Antiviral Drug Major Company Production Sites and Headquarters Table 35. Global Oseltamivir Phosphate Antiviral Drug Company, Product Type & Application Table 36. Global Oseltamivir Phosphate Antiviral Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oseltamivir Phosphate Antiviral Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oseltamivir Phosphate Antiviral Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2021-2026) & (k units) Table 41. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2027-2032) & (k units) Table 46. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 52. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Oseltamivir Phosphate Antiviral Drug Price by Application (2021-2026) & (US$/unit) Table 56. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2027-2032) & (k units) Table 57. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Oseltamivir Phosphate Antiviral Drug Price by Application (2027-2032) & (US$/unit) Table 61. North America Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 62. North America Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 64. Europe Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 68. Latin America Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceuticals Company Information Table 72. Teva Pharmaceuticals Business Overview Table 73. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 75. Teva Pharmaceuticals Recent Development Table 76. SL Pharmaceutica Company Information Table 77. SL Pharmaceutica Business Overview Table 78. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 80. SL Pharmaceutica Recent Development Table 81. Cspc Holdings Company Information Table 82. Cspc Holdings Business Overview Table 83. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 85. Cspc Holdings Recent Development Table 86. Roche Group Company Information Table 87. Roche Group Business Overview Table 88. Roche Group Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Roche Group Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 90. Roche Group Recent Development Table 91. Kelun Pharmaceutical Company Information Table 92. Kelun Pharmaceutical Business Overview Table 93. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 95. Kelun Pharmaceutical Recent Development Table 96. HEC ChangJiang Pharmaceutical Company Information Table 97. HEC ChangJiang Pharmaceutical Business Overview Table 98. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 100. HEC ChangJiang Pharmaceutical Recent Development Table 101. BrightGene Bio-Medical Technology Company Information Table 102. BrightGene Bio-Medical Technology Business Overview Table 103. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 105. BrightGene Bio-Medical Technology Recent Development Table 106. Zydus Cadila Company Information Table 107. Zydus Cadila Business Overview Table 108. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 110. Zydus Cadila Recent Development Table 111. Strides Pharma Inc. Company Information Table 112. Strides Pharma Inc. Business Overview Table 113. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 115. Strides Pharma Inc. Recent Development Table 116. Novadoz Company Information Table 117. Novadoz Business Overview Table 118. Novadoz Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Novadoz Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 120. Novadoz Recent Development Table 121. Natco Pharma Company Information Table 122. Natco Pharma Business Overview Table 123. Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Natco Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 125. Natco Pharma Recent Development Table 126. Macleods Pharmaceuticals Company Information Table 127. Macleods Pharmaceuticals Business Overview Table 128. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 130. Macleods Pharmaceuticals Recent Development Table 131. LUPINE Limited Company Information Table 132. LUPINE Limited Business Overview Table 133. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 135. LUPINE Limited Recent Development Table 136. Hetero Group Company Information Table 137. Hetero Group Business Overview Table 138. Hetero Group Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Hetero Group Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 140. Hetero Group Recent Development Table 141. Camber Pharmaceuticals Company Information Table 142. Camber Pharmaceuticals Business Overview Table 143. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 145. Camber Pharmaceuticals Recent Development Table 146. Amneal Pharmaceuticals Company Information Table 147. Amneal Pharmaceuticals Business Overview Table 148. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 150. Amneal Pharmaceuticals Recent Development Table 151. Alvogen Company Information Table 152. Alvogen Business Overview Table 153. Alvogen Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Alvogen Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 155. Alvogen Recent Development Table 156. Alembic Pharmaceuticals Company Information Table 157. Alembic Pharmaceuticals Business Overview Table 158. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 160. Alembic Pharmaceuticals Recent Development Table 161. Ajanta Pharma Company Information Table 162. Ajanta Pharma Business Overview Table 163. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 165. Ajanta Pharma Recent Development Table 166. North America Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 168. North America Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2026) Table 169. North America Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032) & (k units) Table 170. North America Oseltamivir Phosphate Antiviral Drug Sales Market Share Forecast by Country (2027-2032) Table 171. North America Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026) & (US$ Million) Table 173. North America Oseltamivir Phosphate Antiviral Drug Market Share by Country (2021-2026) Table 174. North America Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America Oseltamivir Phosphate Antiviral Drug Market Share Forecast by Country (2027-2032) Table 176. Europe Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 178. Europe Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2026) Table 179. Europe Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032) & (k units) Table 180. Europe Oseltamivir Phosphate Antiviral Drug Sales Market Share Forecast by Country (2027-2032) Table 181. Europe Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe Oseltamivir Phosphate Antiviral Drug Market Share by Country (2021-2026) Table 184. Europe Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe Oseltamivir Phosphate Antiviral Drug Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 188. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032) & (k units) Table 190. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Share by Country (2021-2026) Table 194. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Share Forecast by Country (2027-2032) Table 196. Latin America Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 197. Latin America Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 198. Latin America Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2026) Table 199. Latin America Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032) & (k units) Table 200. Latin America Oseltamivir Phosphate Antiviral Drug Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America Oseltamivir Phosphate Antiviral Drug Market Share by Country (2021-2026) Table 204. Latin America Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America Oseltamivir Phosphate Antiviral Drug Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 208. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032) & (k units) Table 210. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Share by Country (2021-2026) Table 214. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Oseltamivir Phosphate Antiviral Drug Distributors List Table 219. Oseltamivir Phosphate Antiviral Drug Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Oseltamivir Phosphate Antiviral Drug Image Figure 2. Global Oseltamivir Phosphate Antiviral Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oseltamivir Phosphate Antiviral Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Oseltamivir Phosphate Antiviral Drug Sales (2021-2032) & (k units) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (k units) Figure 7. Suspension Image Figure 8. Global Suspension Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Oseltamivir Phosphate Antiviral Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oseltamivir Phosphate Antiviral Drug Market Share by Type 2025 VS 2032 Figure 11. North America Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oseltamivir Phosphate Antiviral Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Child Image Figure 24. Global Child Sales YoY Growth (2021-2032) & (k units) Figure 25. Aldult Image Figure 26. Global Aldult Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Oseltamivir Phosphate Antiviral Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Oseltamivir Phosphate Antiviral Drug Market Share by Application 2025 VS 2032 Figure 29. North America Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Application in 2025 Figure 30. North America Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Application in 2025 Figure 31. Europe Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Application in 2025 Figure 32. Europe Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Application in 2025 Figure 35. Latin America Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Market Share in Value by Application in 2025 Figure 39. North America Oseltamivir Phosphate Antiviral Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Oseltamivir Phosphate Antiviral Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Oseltamivir Phosphate Antiviral Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Oseltamivir Phosphate Antiviral Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Oseltamivir Phosphate Antiviral Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Oseltamivir Phosphate Antiviral Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oseltamivir Phosphate Antiviral Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Oseltamivir Phosphate Antiviral Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Oseltamivir Phosphate Antiviral Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Oseltamivir Phosphate Antiviral Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oseltamivir Phosphate Antiviral Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Oseltamivir Phosphate Antiviral Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Oseltamivir Phosphate Antiviral Drug Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Oseltamivir Phosphate Antiviral Drug Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Suspension
Applications
  • Child
  • Aldult
Companies covered
  • Teva Pharmaceuticals
  • SL Pharmaceutica
  • Cspc Holdings
  • Roche Group
  • Kelun Pharmaceutical
  • HEC ChangJiang Pharmaceutical
  • BrightGene Bio-Medical Technology
  • Zydus Cadila
  • Strides Pharma Inc.
  • Novadoz
  • Natco Pharma
  • Macleods Pharmaceuticals
  • LUPINE Limited
  • Hetero Group
  • Camber Pharmaceuticals
  • Amneal Pharmaceuticals
  • Alvogen
  • Alembic Pharmaceuticals
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oseltamivir Phosphate Antiviral Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oseltamivir Phosphate Antiviral Drug Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Suspension
  8. 1.4 Global Oseltamivir Phosphate Antiviral Drug Market Size by Type
  9. 1.4.1 Global Oseltamivir Phosphate Antiviral Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oseltamivir Phosphate Antiviral Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oseltamivir Phosphate Antiviral Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oseltamivir Phosphate Antiviral Drug Industry Trends
  2. 2.2 Oseltamivir Phosphate Antiviral Drug Industry Drivers
  3. 2.3 Oseltamivir Phosphate Antiviral Drug Industry Opportunities and Challenges
  4. 2.4 Oseltamivir Phosphate Antiviral Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oseltamivir Phosphate Antiviral Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Oseltamivir Phosphate Antiviral Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Oseltamivir Phosphate Antiviral Drug Price (2021-2026)
  4. 3.4 Global Oseltamivir Phosphate Antiviral Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oseltamivir Phosphate Antiviral Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Oseltamivir Phosphate Antiviral Drug Company, Product Type & Application
  7. 3.7 Global Oseltamivir Phosphate Antiviral Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oseltamivir Phosphate Antiviral Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oseltamivir Phosphate Antiviral Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oseltamivir Phosphate Antiviral Drug Tier 1, Tier 2, and Tier 3
4 Oseltamivir Phosphate Antiviral Drug Regional Status and Outlook
  1. 4.1 Global Oseltamivir Phosphate Antiviral Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oseltamivir Phosphate Antiviral Drug Historic Market Size by Region
  3. 4.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oseltamivir Phosphate Antiviral Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oseltamivir Phosphate Antiviral Drug Forecasted Market Size by Region
  7. 4.3.1 Global Oseltamivir Phosphate Antiviral Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oseltamivir Phosphate Antiviral Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oseltamivir Phosphate Antiviral Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oseltamivir Phosphate Antiviral Drug by Application
  1. 5.1 Oseltamivir Phosphate Antiviral Drug Market by Application
  2. 5.1.1 Child
  3. 5.1.2 Aldult
  4. 5.2 Global Oseltamivir Phosphate Antiviral Drug Market Size by Application
  5. 5.2.1 Global Oseltamivir Phosphate Antiviral Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oseltamivir Phosphate Antiviral Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oseltamivir Phosphate Antiviral Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceuticals
  2. 6.1.1 Teva Pharmaceuticals Company Information
  3. 6.1.2 Teva Pharmaceuticals Business Overview
  4. 6.1.3 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  6. 6.1.5 Teva Pharmaceuticals Recent Developments
  7. 6.2 SL Pharmaceutica
  8. 6.2.1 SL Pharmaceutica Company Information
  9. 6.2.2 SL Pharmaceutica Business Overview
  10. 6.2.3 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product Portfolio
  12. 6.2.5 SL Pharmaceutica Recent Developments
  13. 6.3 Cspc Holdings
  14. 6.3.1 Cspc Holdings Company Information
  15. 6.3.2 Cspc Holdings Business Overview
  16. 6.3.3 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product Portfolio
  18. 6.3.5 Cspc Holdings Recent Developments
  19. 6.4 Roche Group
  20. 6.4.1 Roche Group Company Information
  21. 6.4.2 Roche Group Business Overview
  22. 6.4.3 Roche Group Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
  24. 6.4.5 Roche Group Recent Developments
  25. 6.5 Kelun Pharmaceutical
  26. 6.5.1 Kelun Pharmaceutical Company Information
  27. 6.5.2 Kelun Pharmaceutical Business Overview
  28. 6.5.3 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
  30. 6.5.5 Kelun Pharmaceutical Recent Developments
  31. 6.6 HEC ChangJiang Pharmaceutical
  32. 6.6.1 HEC ChangJiang Pharmaceutical Company Information
  33. 6.6.2 HEC ChangJiang Pharmaceutical Business Overview
  34. 6.6.3 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
  36. 6.6.5 HEC ChangJiang Pharmaceutical Recent Developments
  37. 6.7 BrightGene Bio-Medical Technology
  38. 6.7.1 BrightGene Bio-Medical Technology Company Information
  39. 6.7.2 BrightGene Bio-Medical Technology Business Overview
  40. 6.7.3 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product Portfolio
  42. 6.7.5 BrightGene Bio-Medical Technology Recent Developments
  43. 6.8 Zydus Cadila
  44. 6.8.1 Zydus Cadila Company Information
  45. 6.8.2 Zydus Cadila Business Overview
  46. 6.8.3 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product Portfolio
  48. 6.8.5 Zydus Cadila Recent Developments
  49. 6.9 Strides Pharma Inc.
  50. 6.9.1 Strides Pharma Inc. Company Information
  51. 6.9.2 Strides Pharma Inc. Business Overview
  52. 6.9.3 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product Portfolio
  54. 6.9.5 Strides Pharma Inc. Recent Developments
  55. 6.10 Novadoz
  56. 6.10.1 Novadoz Company Information
  57. 6.10.2 Novadoz Business Overview
  58. 6.10.3 Novadoz Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novadoz Oseltamivir Phosphate Antiviral Drug Product Portfolio
  60. 6.10.5 Novadoz Recent Developments
  61. 6.11 Natco Pharma
  62. 6.11.1 Natco Pharma Company Information
  63. 6.11.2 Natco Pharma Business Overview
  64. 6.11.3 Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Natco Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
  66. 6.11.5 Natco Pharma Recent Developments
  67. 6.12 Macleods Pharmaceuticals
  68. 6.12.1 Macleods Pharmaceuticals Company Information
  69. 6.12.2 Macleods Pharmaceuticals Business Overview
  70. 6.12.3 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  72. 6.12.5 Macleods Pharmaceuticals Recent Developments
  73. 6.13 LUPINE Limited
  74. 6.13.1 LUPINE Limited Company Information
  75. 6.13.2 LUPINE Limited Business Overview
  76. 6.13.3 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product Portfolio
  78. 6.13.5 LUPINE Limited Recent Developments
  79. 6.14 Hetero Group
  80. 6.14.1 Hetero Group Company Information
  81. 6.14.2 Hetero Group Business Overview
  82. 6.14.3 Hetero Group Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hetero Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
  84. 6.14.5 Hetero Group Recent Developments
  85. 6.15 Camber Pharmaceuticals
  86. 6.15.1 Camber Pharmaceuticals Company Information
  87. 6.15.2 Camber Pharmaceuticals Business Overview
  88. 6.15.3 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  90. 6.15.5 Camber Pharmaceuticals Recent Developments
  91. 6.16 Amneal Pharmaceuticals
  92. 6.16.1 Amneal Pharmaceuticals Company Information
  93. 6.16.2 Amneal Pharmaceuticals Business Overview
  94. 6.16.3 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  96. 6.16.5 Amneal Pharmaceuticals Recent Developments
  97. 6.17 Alvogen
  98. 6.17.1 Alvogen Company Information
  99. 6.17.2 Alvogen Business Overview
  100. 6.17.3 Alvogen Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Alvogen Oseltamivir Phosphate Antiviral Drug Product Portfolio
  102. 6.17.5 Alvogen Recent Developments
  103. 6.18 Alembic Pharmaceuticals
  104. 6.18.1 Alembic Pharmaceuticals Company Information
  105. 6.18.2 Alembic Pharmaceuticals Business Overview
  106. 6.18.3 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  108. 6.18.5 Alembic Pharmaceuticals Recent Developments
  109. 6.19 Ajanta Pharma
  110. 6.19.1 Ajanta Pharma Company Information
  111. 6.19.2 Ajanta Pharma Business Overview
  112. 6.19.3 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
  114. 6.19.5 Ajanta Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Oseltamivir Phosphate Antiviral Drug Sales by Country
  2. 7.1.1 North America Oseltamivir Phosphate Antiviral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oseltamivir Phosphate Antiviral Drug Market Size by Country
  6. 7.2.1 North America Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oseltamivir Phosphate Antiviral Drug Sales by Country
  2. 8.1.1 Europe Oseltamivir Phosphate Antiviral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oseltamivir Phosphate Antiviral Drug Market Size by Country
  6. 8.2.1 Europe Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales by Country
  2. 9.1.1 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oseltamivir Phosphate Antiviral Drug Sales by Country
  2. 10.1.1 South America Oseltamivir Phosphate Antiviral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oseltamivir Phosphate Antiviral Drug Market Size by Country
  6. 10.2.1 South America Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country
  2. 11.1.1 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oseltamivir Phosphate Antiviral Drug Value Chain Analysis
  2. 12.1.1 Oseltamivir Phosphate Antiviral Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oseltamivir Phosphate Antiviral Drug Production Mode & Process
  7. 12.2 Oseltamivir Phosphate Antiviral Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oseltamivir Phosphate Antiviral Drug Distributors
  10. 12.2.3 Oseltamivir Phosphate Antiviral Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst